GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hyundai Bioscience Co Ltd (XKRX:048410) » Definitions » Additional Paid-In Capital

Hyundai Bioscience Co (XKRX:048410) Additional Paid-In Capital : ₩48,239 Mil(As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Hyundai Bioscience Co Additional Paid-In Capital?


Hyundai Bioscience Co's quarterly additional paid-in capital increased from Sep. 2023 (₩48,069 Mil) to Dec. 2023 (₩48,090 Mil) and increased from Dec. 2023 (₩48,090 Mil) to Mar. 2024 (₩48,239 Mil).

Hyundai Bioscience Co's annual additional paid-in capital increased from Dec. 2021 (₩142,670 Mil) to Dec. 2022 (₩154,739 Mil) but then declined from Dec. 2022 (₩154,739 Mil) to Dec. 2023 (₩48,090 Mil).


Hyundai Bioscience Co Additional Paid-In Capital Historical Data

The historical data trend for Hyundai Bioscience Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyundai Bioscience Co Additional Paid-In Capital Chart

Hyundai Bioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 102,944.92 114,193.63 142,669.65 154,738.99 48,090.45

Hyundai Bioscience Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47,801.63 48,013.39 48,068.93 48,090.45 48,239.19

Hyundai Bioscience Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Hyundai Bioscience Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Hyundai Bioscience Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Hyundai Bioscience Co (XKRX:048410) Business Description

Traded in Other Exchanges
N/A
Address
150 North-Ahyun Road, 3rd Floor Academic Cooperation Building, Ehwa Women’s University, Seodaemun-gu, Seoul, KOR
Hyundai Bioscience Co Ltd is a Korean biotechnology company. The company is engaged in developing and commercializing bio-fusion technology with the purpose of delivering active ingredients safely and efficiently to the body. It has developed Vitabrid CG, a biomaterial that binds vitamin C with bio-friendly mineral layers, which is a beneficial ingredient in skin brightening, anti-aging, and anti-inflammation; and Vitabrid C12, a premium skincare brand.

Hyundai Bioscience Co (XKRX:048410) Headlines

No Headlines